May Christopher John
Known title: VP & CFOCIK: 0001650230
Associated companies
Transaction History
| DCH | ▲ Buy | Grant | 39,120 | $0 | 2/28/2026 | View on chart |
| DCH | ▼ Sell | Tax Withholding | 17,526 | $116K | 2/28/2026 | View on chart |
| DCH | ▼ Sell | Tax Withholding | 34,907 | $230K | 2/28/2026 | View on chart |
| DCH | ▲ Buy | Grant | 113,738 | $0 | 2/26/2026 | View on chart |
| DCH | ▲ Buy | Grant | 287,879 | — | 2/2/2026 | View on chart |
| DCH | ▲ Buy | Grant | 142,106 | $0 | 3/3/2025 | View on chart |
| DCH | ▼ Sell | Tax Withholding | 37,193 | $184K | 2/28/2025 | View on chart |
| DCH | ▼ Sell | Tax Withholding | 21,302 | $106K | 2/28/2025 | View on chart |
| DCH | ▲ Buy | Grant | 46,077 | $0 | 2/28/2025 | View on chart |
| DCH | ▲ Buy | Grant | 99,853 | $675K | 3/4/2024 | View on chart |
| DCH | ▲ Buy | Grant | 68,023 | $0 | 3/1/2024 | View on chart |
| DCH | ▼ Sell | Tax Withholding | 30,475 | $209K | 3/1/2024 | View on chart |
| DCH | ▼ Sell | Tax Withholding | 36,048 | $248K | 3/1/2024 | View on chart |
| DCH | ▲ Buy | Grant | 163,717 | $0 | 3/6/2023 | View on chart |
| DCH | ▼ Sell | Tax Withholding | 72,527 | $667K | 3/6/2023 | View on chart |
| DCH | ▼ Sell | Tax Withholding | 56,884 | $523K | 3/6/2023 | View on chart |
| DCH | ▲ Buy | Grant | 76,705 | $675K | 2/28/2023 | View on chart |
| DCH | ▼ Sell | Tax Withholding | 12,832 | $102K | 3/4/2022 | View on chart |
| DCH | ▲ Buy | Grant | 83,019 | $769K | 2/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Dauch names new CFO, faces lower price targets from Barclays and UBS
Dauch Corporation announced a financial leadership change, appointing Nathan Iles as CFO effective December 1 to succeed Christopher May. This executive shift coincides with recent analyst actions, as both Barclays and UBS lowered their price targets to $8 while maintaining their respective ratings. The stock has experienced a significant decline since February, currently trading near its 52-week low, which has prompted discussions about potential undervaluation despite the recent downward revisions.
Dauch names new CFO, faces lower price targets from Barclays and UBS. Dauch Corporation announced a financial leadership change, appointing Nathan Iles as CFO effective December 1 to succeed Christopher May. This executive shift coincides with recent analyst actions, as both Barclays and UBS lowered their price targets to $8 while maintaining their respective ratings. The stock has experienced a significant decline since February, currently trading near its 52-week low, which has prompted discussions about potential undervaluation despite the recent downward revisions.